An update on the long-term outcomes of prenatal dexamethasone treatment in congenital adrenal hyperplasia

First-trimester prenatal treatment with glucocorticoid (GC) dexamethasone (DEX) in pregnancies at risk for classic congenital adrenal hyperplasia (CAH) is associated with ethical dilemmas. Though effective in reducing virilisation in girls with CAH, it entails exposure to high doses of GC in fetuses...

Descripción completa

Detalles Bibliográficos
Autores principales: van’t Westeinde, Annelies, Karlsson, Leif, Messina, Valeria, Wallensteen, Lena, Brösamle, Manuela, Dal Maso, Giorgio, Lazzerini, Alessandro, Kristensen, Jette, Kwast, Diana, Tschaidse, Lea, Auer, Matthias K, Nowotny, Hanna F, Persani, Luca, Reisch, Nicole, Lajic, Svetlana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083667/
https://www.ncbi.nlm.nih.gov/pubmed/36752813
http://dx.doi.org/10.1530/EC-22-0400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083667/
https://www.ncbi.nlm.nih.gov/pubmed/36752813
http://dx.doi.org/10.1530/EC-22-0400

Ejemplares similares